Correlation analysis between neutrophil/lymphocyte ratio with Lee’s grading and Oxford classification of IgA nephropathy

doi:10.3969/j.issn.1004-583X.2021.05.009

Abstract

Abstract:

Objective To analyze the correlation between neutrophil /lymphocyte ratio(NLR) and Lee’s grading and Oxford classification of immunoglobulin A (IgA) nephropathy. Methods The data of clinical and pathological of 80 IgA nephropathy patients were selected, the patients were subject to the grading and grouping based on Lee's grading standard for pathology of IgA nephropathy, interstitial fibrosis and tubuloatrophy (T) grading standard of Oxford classification and were divided into two groups according to the crescents (C) grading standard of Oxford classification.The serum NLR,hypersensitive C-reactive protein (hsCRP), serum creatinine (SCr), blood urea nitrogen (BUN), 24 h urinary protein were determined. The glomerular filtration rate(eGFR) was estimated by modification of diet in renal disease equation. The correlation of NLR with Lee’s grading, Oxford classification and various clinical indicators of renal function were analyzed. Results In Lee’s grading and Oxford classification, NLR,SCr, BUN and 24 h urinary protein were gradually increased with the aggravating degree of renal pathological lesions, while eGFR gradually decreased (P<0.05). NLR was positively correlated with T and C gradings in Lee’s grading and Oxford classification as well as SCr, BUN, 24 h urinary protein (P<0.05),but negatively correlated with eGFR(P<0.05). Conclusion NLR can reflect the inflammatory state and activity of IgA nephropathy patients, and it is greatly correlated with the degree of pathological damage and renal function, delivering certain value in evaluating the renal injury degree and prognosis of IgA nephropathy.

Key words: glomerulonephritis, IGA, neutrophil/lymphocyte, Lee’s grading, Oxford classification

CLC Number:

R692.31

Liu Jiali, Xie Rong, Li Xuelian, Liu Xiaohui. Correlation analysis between neutrophil/lymphocyte ratio with Lee’s grading and Oxford classification of IgA nephropathy[J]. Clinical Focus, 2021, 36(5): 432-435.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2021.05.009

https://huicui.hebmu.edu.cn/EN/Y2021/V36/I5/432

Figures/Tables 6

References 19

[1]	Béné MC, Hurault De Ligny B, Kessler M, et al. Confirmation of tonsillar anomalies in IgA nephropathy: A multicenter study[J]. Nephron, 1991, 58(4):425-428. pmid: 1922607
[2]	Yang Y, Zhang Z, Zhuo L, et al. The spectrum of biopsy-proven glomerular disease in China: A systematic review[J]. Chin Med J (Engl), 2018, 131(6):731-735.
[3]	Paquissi FC. The role of inflammation in cardiovascular diseases: The predictive value of neutrophil-lymphocyte ratio as a marker in peripheral arterial disease[J]. Ther Clin Risk Manag, 2016, 12:851-860.
[4]	Pine JK, Morris E, Hutchins GG, et al. Systemic neutrophil-to-lymphocyte ratio in colorectal cancer: The relationship to patient survival, tumour biology and local lymphocytic response to tumour[J]. Br J Cancer, 2015, 113(2):204-211. doi: 10.1038/bjc.2015.87 URL
[5]	张国娟, 黄雯, 陈燊. 中性粒细胞淋巴细胞比值在评价慢性肾脏病患者炎症状态中的作用[J]. 中国血液净化, 2015, 14(4):482-485.
[6]	邹万忠. 肾活检病理学[M].第2版. 北京大学医学出版社, 2009:58-169.
[7]	Zhou FD, Zhao MH, Zou WZ, et al. The changing spectrum of primary glomerular diseases within 15 years: A survey of 3331 patients in a single Chinese centre[J]. Nephrol Dial Transplant, 2009, 24(3):870-876. doi: 10.1093/ndt/gfn554 URL
[8]	Feriozzi S, Polci R. The role of tonsillectomy in IgA nephropathy[J]. J Nephrol, 2016, 29(1):13-19. doi: 10.1007/s40620-015-0247-4 pmid: 26582216
[9]	Zhu TT, Wang L, Wang HL, et al. Helicobacter pylori participates in the pathogenesis of IgA nephropathy[J]. Ren Fail, 2016, 38(9):1398-1404. doi: 10.1080/0886022X.2016.1216713 URL
[10]	Rollino C, Vischini G, Coppo R. IgA nephropathy and infections[J]. J Nephrol, 2016, 29(4):463-468. doi: 10.1007/s40620-016-0265-x URL
[11]	Guo ZX, Wei W, Zhong C, et al. Correlation of preoperative neutrophil-to-lymphocyte ratio to prognosis of young patients with hepatocellular carcinoma[J]. Ai Zheng, 2009, 28(11):1203-1208.
[12]	Hu ZD, Sun Y, Guo J, et al. Red blood cell distribution width and neutrophil/lymphocyte ratio are positively correlated with disease activity in primary Sjögren's syndrome[J]. Clin Biochem, 2014, 47(18):287-290. doi: 10.1016/j.clinbiochem.2014.08.022 URL
[13]	Uslu AU, Küçük A, Şahin A, et al. Two new inflammatory markers associated with Disease Activity Score-28 in patients with rheumatoid arthritis: Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio[J]. Int J Rheum Dis, 2015, 18(7):731-735. doi: 10.1111/apl.2015.18.issue-7 URL
[14]	赵春梅, 袁宏伟. IgA肾病组织病理学特点与临床预后关系研究[J]. 中华实用诊断与治疗杂志, 2015, (6):589-590.
[15]	李卅立, 范秋灵, 赵洁, 等. IgA肾病牛津分型与临床指标的相关性及危险因素分析[J]. 中国医科大学学报, 2017, 46(1):1-6.
[16]	Tumlin JA, Lohavichan V, Hennigar R. Crescentic, proliferative IgA nephropathy: Clinical and histological response to methylprednisolone and intravenous cyclophosphamide[J]. Nephrol Dial Transplant, 2003, 18(7):1321-1329. doi: 10.1093/ndt/gfg081 URL
[17]	杨艳燕, 陶涛, 罗朋立, 等. 不同中性粒细胞与淋巴细胞比值IgA肾病患者临床特征比较及其影响因素分析[J]. 山东医药, 2018, 58(46):49-52.
[18]	张春雷, 李欣蓉, 曾学辉. 炎症介质在IgA肾病中的临床应用价值探讨[J]. 免疫学杂志, 2018, 34(4):348-352.
[19]	Huang W, Huang J, Liu Q, et al. Neutrophil-lymphocyte ratio is a reliable predictive marker for early-stage diabetic nephropathy[J]. Clin Endocrinol (Oxf), 2015, 82(2):229-233. doi: 10.1111/cen.12576 URL

等级	病理表现
Ⅰ级	肾小球绝大多数正常,偶尔轻度系膜增宽(节段)伴和(或)不伴细胞增生,肾小管和肾间质没有改变。
Ⅱ级	肾小球示局灶系膜增殖和硬化(<50%),有罕见小的新月体,肾小管和肾间质无损害。
Ⅲ级	肾小球呈弥漫性系膜增值和增宽(偶尔局灶节段),偶见小新月体;肾小管和肾间质改变则呈现出局灶性肾间质水肿,偶见细胞浸润,罕见肾小管萎缩。
Ⅳ级	肾小球病变呈重度弥漫性系膜增生和硬化,部分或全部肾小球硬化,可见新月体(<45%)。肾小管萎缩,肾间质浸润,偶见肾间质泡沫细胞。
Ⅴ级	肾小球病变的性质类似Ⅳ级,但更严重,肾小球新月体形成>45%;肾小管和肾间质病变类似于Ⅳ级,但更严重。

等级	病理表现
Ⅰ级	肾小球绝大多数正常,偶尔轻度系膜增宽(节段)伴和(或)不伴细胞增生,肾小管和肾间质没有改变。
Ⅱ级	肾小球示局灶系膜增殖和硬化(<50%),有罕见小的新月体,肾小管和肾间质无损害。
Ⅲ级	肾小球呈弥漫性系膜增值和增宽(偶尔局灶节段),偶见小新月体;肾小管和肾间质改变则呈现出局灶性肾间质水肿,偶见细胞浸润,罕见肾小管萎缩。
Ⅳ级	肾小球病变呈重度弥漫性系膜增生和硬化,部分或全部肾小球硬化,可见新月体(<45%)。肾小管萎缩,肾间质浸润,偶见肾间质泡沫细胞。
Ⅴ级	肾小球病变的性质类似Ⅳ级,但更严重,肾小球新月体形成>45%;肾小管和肾间质病变类似于Ⅳ级,但更严重。

病变部位	分级	病理表现
系膜增殖(M)	M0	<4个系膜细胞/系膜区
	M1	≥4个系膜细胞/系膜区
毛细血管内增生性病变(E)	E0	无增生性病变
	E1	有增生性病变
节段硬化与粘连(S)	S0	无硬化或粘连
	S1	有硬化或粘连
间质纤维化与小管萎缩(T)	T0	纤维化或萎缩≤25%
	T1	25%<纤维化或萎缩≤50%
	T2	纤维化或萎缩>50%
新月体(C)	C0	无新月体
	C1	有新月体,且新月体<25%
	C2	有新月体,且新月体≥25%

病变部位	分级	病理表现
系膜增殖(M)	M0	<4个系膜细胞/系膜区
	M1	≥4个系膜细胞/系膜区
毛细血管内增生性病变(E)	E0	无增生性病变
	E1	有增生性病变
节段硬化与粘连(S)	S0	无硬化或粘连
	S1	有硬化或粘连
间质纤维化与小管萎缩(T)	T0	纤维化或萎缩≤25%
	T1	25%<纤维化或萎缩≤50%
	T2	纤维化或萎缩>50%
新月体(C)	C0	无新月体
	C1	有新月体,且新月体<25%
	C2	有新月体,且新月体≥25%

组别	例数	NLR	hsCRP (mg/L)	SCr (μmol/L)	BUN (mmol/L)	eGFR [ml/(min· 1.73 m²)]	24 h尿蛋白 (mg)
Ⅰ~Ⅱ级组	42	2.00(1.62,2.46)	0.73(0.25,2.02)	73.20(55.35,93.35)	4.835(3.880,5.573)	100.67±32.07	800.95(400.88,1 663.35)
Ⅲ级组	14	2.57(2.06,3.19)	0.87(0.23,1.66)	82.95(68.70,102.00)	5.255(4.345,5.873)	85.32±23.39	2 435.20(1 105.88,4 796.30)
Ⅳ~Ⅴ级组	18	3.20(2.82,4.26)	1.91(0.33,2.90)	126.40(95.95,162.65)	6.540(5.365,9.525)	57.79±24.94	4 215.55(3 218.35,6 428.68)
统计值		χ²=22.891	χ²=1.164	χ²=17.505	χ²=9.723	F=15.187	χ²=31.25
P值		<0.05	>0.05	<0.05	<0.05	<0.05	<0.05